Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2024 Aug 3;24:274. doi: 10.1186/s12935-024-03461-8

Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome

Shahram Taeb 1, Davoud Rostamzadeh 2, Seyed Mohammad Amini 3, Mohammad Rahmati 4, Mohammad Eftekhari 4, Arash Safari 5,6, Masoud Najafi 7,8,9,✉
PMCID: PMC11297613  PMID: 39097737

Correction to: Cancer Cell International (2024) 24:233

10.1186/s12935-024-03420-3

In this article [1], the affiliation details for the author Arash Safari were incorrectly given as ‘Department of Radiology, Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz 71439 − 14693, Iran’ but should have been ‘Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran and Department of Radiology, Paramedical School, Shiraz University of Medical Sciences, Shiraz, Iran’.

Footnotes

The online version of the original article can be found at 10.1186/s12935-024-03420-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Taeb S, Rostamzadeh D, Amini SM, Rahmati M, Eftekhari M, Safari A, Najafi M. MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome. Cancer Cell Int. 2024;24(1):233. 10.1186/s12935-024-03420-3 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES